MEDX Xelerator
MEDX Xelerator is an Israel Innovation Authority-backed medical device incubator that funds, develops, and supports early-stage startups addressing vascular, cardiology, urology, oncology, robotics, and digital health unmet clinical needs for global markets.
- Company typePrivate
- Founded2015
- HeadquartersOr Yehuda, Israel
- Headcount11–50
- GTM typeB2B
- OfferingServices
What MEDX Xelerator does
MEDX Xelerator is a privately held Israeli medical device and digital health incubator operating under the Israel Innovation Authority. Founded in 2015 as a partnership between MEDX Ventures Group, Boston Scientific, Intellectual Ventures, and Sheba Medical Center, the firm identifies, funds, and nurtures early-stage medical device ventures that address major unmet clinical needs. Its focus areas include vascular interventions, interventional cardiology, urology, interventional oncology, medical robotics, and home- and clinic-based digital health solutions. The incubator operates from Or Yehuda and Sakhnin, Israel, with a management team of approximately 10–20 senior medtech operators supported by an in-house R&D facility (X-Lab) and a global scientific advisory board.
The firm provides each admitted portfolio company with a structured support package covering R&D, regulatory affairs, business development, finance, IP protection, reimbursement strategy, marketing and sales, and clinical trial access — leveraging partners such as Sheba Medical Center (FederalWide Assurance certification), Boston Scientific, West Pharmaceutical Services, and Weill Cornell Medicine. Standard incubator investment terms are over $800,000 for a two-year period and up to $1.1 million for a three-year period, augmented by follow-on investments. Since inception, the incubator has created and backed 16 portfolio companies including EndoWays (acquired by Ascendum in February 2021), Append Medical, Exero Medical, Synchrony Medical, VeinWay, EyeMed Technologies, CAPS Medical, PatenSee, SwiftDuct, and Urologic Health.
MEDX Xelerator's revenue mechanics differ from a traditional product company: it generates returns through equity appreciation in portfolio companies, M&A exits, and follow-on investment gains, with capital sourced from strategic corporate partners (Boston Scientific, CBG) and Israeli innovation frameworks. Notable capital flows include a $20 million allocation from Consensus Business Group in July 2021 and the September 2024 launch of Edge Medical Ventures, a $70 million successor medtech fund founded by the incubator's own veterans. The customer base is the portfolio itself — early-stage medical device startups — supported by a network of international strategic investors and clinical collaborators in Israel, the United States, and Europe.
MEDX Xelerator firmographics
Firmographics- Name
- MEDX Xelerator
- Legal name
- MEDX Xelerator LP
- Website
- https://medxelerator.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MEDX Xelerator is an Israel Innovation Authority-backed medical device incubator that funds, develops, and supports early-stage startups addressing vascular, cardiology, urology, oncology, robotics, and digital health unmet clinical needs for global markets.
- Ownership category
- akta.pro rank
MEDX Xelerator industry classification
Industry- Product category
- Medical Device Incubator Services
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Accelerators & Incubators (Investor-Operated) (FSANAAAM)
Keywords
Where MEDX Xelerator is headquartered
LocationHeadquarters
- HQ city
- Or Yehuda
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
MEDX Xelerator business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Incubator Investment Returns: MEDX Xelerator invests in early-stage medical device startups and generates returns through equity appreciation, M&A exits (e.g., EndoWays acquired by Ascendum in 2021), and follow-on investments. The incubator operates under the Israel Innovation Authority and is funded by strategic partners including Boston Scientific, CBG, and Sheba Medical Center.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Incubator investment and support program |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
MEDX Xelerator product offering
Product offeringCore offering
MEDX Xelerator is a leading Israeli medical-device-focused incubator and investor operating under the auspices of the Israel Innovation Authority. It identifies and nurtures early-stage medical device startups by providing seed funding (over $800,000 for 2 years, up to $1.1 million for 3 years), R&D support through an in-house X-Lab, business development, regulatory affairs, marketing and sales guidance, IP protection, clinical trial access, and reimbursement strategy. The incubator's portfolio spans 16 companies developing technologies in vascular interventions, interventional cardiology, urology, interventional oncology, medical robotics, and home- and clinic-based digital health solutions.
Product overview
MEDX Xelerator is a leading Israeli medical-device-focused incubator operating under the Israel Innovation Authority. Rather than offering a unified product platform, it nurtures and invests in portfolio companies developing distinct medical device technologies. The portfolio spans 16 companies addressing vascular interventions, interventional cardiology, urology, interventional oncology, medical robotics, respiratory therapy, dialysis monitoring, and digital health solutions. Key products include Exero Medical's xBar (post-surgical tissue monitoring), Append Medical's Appliator (LAA closure), Synchrony Medical's LibAirty (airway clearance), VeinWay's Traversa (venous disease), EyeMed's VaLens (adjustable IOL), and others. The incubator provides funding (over $800K for 2 years, up to $1.1M for 3 years), R&D support, regulatory affairs guidance, and access to strategic partners including Boston Scientific and Sheba Medical Center.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Device Incubator Program A multi-year incubation program that scouts, evaluates, funds, and nurtures early-stage medical device startups from concept to commercialization. Provides over $800,000 in funding for 2 years and up to $1.1 million for 3 years per portfolio company, plus comprehensive operational support including R&D, business development, regulatory affairs, marketing & sales, reimbursement, IP protection, and clinical trial access. Targets innovations in vascular, interventional cardiology, urology, interventional oncology, medical robotics, and home- and clinic-based digital health.
- X-Lab Creative Solution Creation A professional in-house dedicated laboratory with state-of-the-art equipment available to portfolio companies for R&D activities, enabling creative solution creation and supporting international-level R&D activities throughout the medical device development lifecycle.
Quantifiable outcome
- EndoWays (disposable robotics for CathLab) - M&A February 2021
- +2 more outcomes
Companies that use MEDX Xelerator
Customer profileNamed customers5 records
Segments1 record
Ideal customer profiles1 record
MEDX Xelerator technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
MEDX Xelerator partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered major, core and minor.
- Edge Medical Venturesmajor$70 million medtech fund launched by MEDX Xelerator veterans (Shai Policker, Gal Atarot, Noam Taichler) as alumni of the incubator. Operates venture studio identifying and developing medical devices in collaboration with strategic partners, healthcare professionals, and industry experts. Anchor investors include CBG.
- Weill Cornell Medicine Enterprise InnovationmajorSigned Xplore program agreement with MEDX Xelerator in September 2023 as part of the venture creation program to identify and develop medical device innovations with global commercialization potential.
- The Portland TrustmajorUK-based organization that partnered with MEDX Xelerator to establish a northern branch in Sakhnin Valley as part of Portland's Economic Regional Growth Engine Program - Health Cluster, aimed at enhancing local MedTech innovation.
- West PharmaceuticalsmajorU.S. pharma giant (NYSE: WST) that signed strategic collaboration with MEDX Xelerator in November 2021 to expand global early-stage innovation program to include Israeli medical inventions that fill unmet clinical needs.
- Sheba Medical CentercoreIsrael's national medical center at Tel Hashomer, adjacent to Tel Aviv. Most comprehensive medical center in Middle East with over 800 clinical trials per year. Provides clinical site access, physician network, FederalWide Assurance certification, and innovation commercialization support.
- MEDX Ventures GroupcoreInvestment and management firm founded in 2010 with offices in Israel, USA, and Europe. Focuses on active management of medical ventures and technologies based in Israel. Founded by Harel Gadot, MEDX Ventures Group established MEDX Xelerator as a partnership.
- Wolfson HospitalminorListed as a collaborator of MEDX Xelerator, providing additional clinical site access for portfolio companies.
- Ichilov HospitalminorListed as a collaborator of MEDX Xelerator, providing additional clinical site access for portfolio companies.
- Galilee Medical CenterminorListed as a collaborator of MEDX Xelerator, hosting clinical studies including SwiftDuct's first clinical study.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
MEDX Xelerator competitors and assessment
Company assessmentDirect peers
- Trendlines Medical: Israeli medical device and agrifood-tech incubator listed on SGX. Operates a comparable incubation model, taking equity stakes in early-stage medical device startups and providing hands-on R&D, clinical, and business support — directly comparable to MEDX Xelerator's value proposition.
- MindUP: Israel Innovation Authority-backed digital health incubator founded with partners including Pitango, IBM, and Medtronic. Closely comparable as a digital-health-focused Israeli incubator leveraging corporate venture backing and IIA funding.
- Hatch Medical: US-based medical device incubator and technology brokerage that partners with entrepreneurs to develop and commercialize novel interventional and surgical devices. Comparable role in sourcing and accelerating medical device startups.
- Fogarty Innovation: Non-profit medical device incubator and accelerator based in Silicon Valley providing mentorship, education, and resources to early-stage medtech entrepreneurs. Direct peer in the medical device venture-creation model.
- MedTech Innovator: Largest medical device accelerator program globally, running an annual cohort and alumni network with corporate sponsors (J&J, Baxter, BD, Olympus). Comparable accelerator model with corporate venture backing.
- NGT (Next Generation Technology) Ventures: Israeli technology incubator and seed investor focusing on medical devices and biotech with backing from medical industry leaders. Direct comparable as another IIA-affiliated Israeli medical device incubator.
Broad incumbents
- JLABS by Johnson & Johnson Innovation: Global network of Johnson & Johnson innovation accelerators supporting early-stage healthcare and medtech startups with lab space, mentorship, and capital. Broader incumbent operating at scale across multiple geographies and therapeutic areas.
- UCSF Rosenman Institute: University-affiliated health technology incubator connecting startups with clinicians, investors, and industry partners. Comparable clinical-affiliation-driven incubation model leveraging a major US hospital system.
- Cedars-Sinai Accelerator: Hospital-affiliated accelerator program for healthcare and medical device startups providing clinical validation, mentorship, and pilot deployment opportunities. Comparable to MEDX's hospital partnership model with Sheba Medical Center.
- MATTER: Chicago-based healthcare innovation incubator and accelerator supporting healthtech, medical device, and digital health startups through mentorship, corporate partnerships, and programming. Comparable broad-incumbent incubator model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
MEDX Xelerator social profiles
Digital presenceMEDX Xelerator financial estimates
Financial estimateRevenue estimate
Valuation estimate
MEDX Xelerator leadership team
Management profileNumber of profiles
Profiles16 records
MEDX Xelerator subsidiaries and ownership
Company hierarchySubsidiaries1 record
MEDX Xelerator funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MEDX Xelerator M&A and investment
M&A and investmentM&A
Investments7 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MEDX Xelerator
What does MEDX Xelerator do?
MEDX Xelerator is a leading Israeli medical-device-focused incubator and investor operating under the auspices of the Israel Innovation Authority. It identifies and nurtures early-stage medical device startups by providing seed funding (over $800,000 for 2 years, up to $1.1 million for 3 years), R&D support through an in-house X-Lab, business development, regulatory affairs, marketing and sales guidance, IP protection, clinical trial access, and reimbursement strategy. The incubator's portfolio spans 16 companies developing technologies in vascular interventions, interventional cardiology, urology, interventional oncology, medical robotics, and home- and clinic-based digital health solutions.
Is MEDX Xelerator a public or private company?
MEDX Xelerator is a private company. It is classified as venture growth investor backed and is currently operating.
When was MEDX Xelerator founded?
MEDX Xelerator was founded in 2015. It employs 11 to 50 people.
Where is MEDX Xelerator based?
MEDX Xelerator is headquartered in Or Yehuda, Israel, in the Middle East region.
How does MEDX Xelerator make money?
One revenue line is on record: incubator Investment Returns.
Who are MEDX Xelerator's main competitors?
Direct peers on record are Trendlines Medical, MindUP, Hatch Medical, Fogarty Innovation, MedTech Innovator and NGT (Next Generation Technology) Ventures. Broad incumbents are JLABS by Johnson & Johnson Innovation, UCSF Rosenman Institute, Cedars-Sinai Accelerator and MATTER.
Does MEDX Xelerator have an API?
No public API is recorded for MEDX Xelerator.
What industry is MEDX Xelerator in?
MEDX Xelerator's product category is Medical Device Incubator Services. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated). Its NAICS code is 5417 and its SIC code is 8731.